1-Ethyl-4,4-difluorocyclohexane-1-carboxylic acid | 1389315-01-8

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 卤代烷
• 英文名称: 1-Ethyl-4,4-difluorocyclohexane-1-carboxylic acid
• CAS: 1389315-01-8
• 化学式: C₉H₁₄F₂O₂
• 分子量: 192.2
• InChiKey: YBAXHQHIEFEKIF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• AMINO ACID COMPOUNDS AND METHODS OF USE
  申请人：Pliant Therapeutics, Inc.

  公开号：US20200109141A1

  公开（公告）日：2020-04-09

  The invention relates to compounds of formula (I): or a salt thereof, wherein R 1 , G, L 1 , L 2 , L 3 , and Y are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are inhibitors of one, or both of, αvβ 1 integrin and αvβ 6 integrin that are useful for treating fibrosis such as in nonalcoholic steatohepatitis (NASH), idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).

  本发明涉及如下公式(I)的化合物： 或其盐，其中R1、G、L1、L2、L3和Y如本文所述。公式(I)的化合物及其药物组合物是αvβ1整合素和/或αvβ6整合素的一种或两种的抑制剂，用于治疗纤维化，如非酒精性脂肪肝炎（NASH）、特发性肺纤维化（IPF）和非特异性间质性肺炎（NSIP）。
• SUBSTITUTED 3-(BIPHENYL-3-YL)-8,8-DIFLUORO-4-HYDROXY-1-AZASPIRO[4.5]DEC-3-EN-2-ONES FOR THERAPY
  申请人：Liu Ningshu

  公开号：US20140011853A1

  公开（公告）日：2014-01-09

  The invention relates to substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones of the formula (Ia) for therapeutic purposes, to pharmaceutical compositions and to their use in therapy, in particular for the prophylaxis and therapy of tumour disorders. The invention also relates to novel compounds of the formula (I) in which W, X, Y, Z, A, B, D and G have the meanings given above, to a plurality of processes and intermediates for their preparation, and to their use as pesticides and/or herbicides and/or fungicides. The invention also relates to selectively herbicidal compositions comprising, firstly, the halogen-substituted spirocyclic ketoenols and, secondly, a crop plant compatibility-improving compound. The present invention furthermore relates to the boosting of the action of crop protection compositions comprising, in particular, halogen-substituted spirocyclic ketoenols, through the addition of ammonium salts or phosphonium salts and optionally penetrants, to the corresponding compositions, to processes for producing them and to their application in crop protection as pesticides and/or fungicides and/or for preventing unwanted plant growth.

  该发明涉及用于治疗目的的取代3-(联苯基-3-基)-8,8-二氟-4-羟基-1-氮杂螺[4.5]癸-3-烯-2-酮（Ia）的化合物，以及药物组合物和它们在治疗中的使用，特别是用于预防和治疗肿瘤疾病。该发明还涉及新化合物（I）的化合物，其中W、X、Y、Z、A、B、D和G具有上述给定的含义，以及用于它们的制备的多种过程和中间体，以及它们作为杀虫剂和/或除草剂和/或杀菌剂的用途。该发明还涉及选择性除草剂组合物，首先包括卤素取代的螺环酮醇，其次包括一种提高作物植物兼容性的化合物。本发明还涉及通过向作物保护组合物中添加铵盐或磷铵盐以及可选的渗透剂，从而提高作物保护组合物的作用，特别是卤素取代的螺环酮醇，以及它们的生产过程和在作物保护中作为杀虫剂和/或杀菌剂和/或用于预防不受欢迎的植物生长的应用。
• Therapeutic Agents
  申请人：Blackaby Wesley Peter

  公开号：US20090286765A1

  公开（公告）日：2009-11-19

  A compound of the formula (I): wherein R 1 , R 2 , R 3 , R 4 , Ar, A, n and m are defined herein, is disclosed as a GlyT1 inhibitor; pharmaceutical compositions containing the compound of the formula (I) are also disclosed as are their use in medicine, for example in the treatment of schizophrenia.

  公开了一种化合物的公式（I）：其中R1，R2，R3，R4，Ar，A，n和m在此定义，作为GlyT1抑制剂；还公开了含有公式（I）化合物的药物组合物，以及它们在医学上的用途，例如用于治疗精神分裂症。
• SUBSTITUTED 3-(BIPHENYL-3-YL)-8,8-DIFLUORO-4-HYDROXY-1-AZASPIRO[4.5]DEC-3-EN-2-ONES FOR THERAPY AND HALOGEN-SUBSTITUTED SPIROCYCLIC KETOENOLS
  申请人：Bretschneider Thomas

  公开号：US20140045696A1

  公开（公告）日：2014-02-13

  The invention relates to novel compounds of the formula (I) in which W, X, Y, Z, A, B, D and G have the meanings given above, to a plurality of processes and intermediates for their preparation, and to their use as pesticides and/or herbicides and/or fungicides. The invention also relates to selective herbicidal compositions comprising, firstly, the halogen-substituted spirocyclic ketoenols and, secondly, a crop plant compatibility-improving compound. The present invention furthermore relates to the boosting of the action of crop protection compositions comprising, in particular, halogen-substituted spirocyclic ketoenols, through the addition of ammonium salts or phosphonium salts and optionally penetrants, to the corresponding compositions, to processes for producing them and to their application in crop protection as pesticides and/or fungicides and/or for preventing unwanted plant growth. The invention also relates to substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones of the formula (Ia) for therapeutic purposes, to pharmaceutical compositions and to their use in therapy, in particular for the prophylaxis and therapy of tumor disorders.

  本发明涉及公式（I）的新化合物，其中W，X，Y，Z，A，B，D和G具有上述给定的含义，以及其制备的多种过程和中间体，以及它们作为杀虫剂和/或除草剂和/或杀菌剂的用途。本发明还涉及选择性除草剂组合物，其包括第一，卤代螺环酮烯醇，第二，作物植物相容性改良化合物。本发明还涉及通过向相应的组合物添加铵盐或膦盐和可选的渗透剂，从而提高特别是卤代螺环酮烯醇的作物保护组合物的作用的方法，以及生产它们的过程和它们在作物保护中作为杀虫剂和/或杀菌剂和/或防止不良植物生长的应用。本发明还涉及公式（Ia）的取代3-（联苯基-3-基）-8,8-二氟-4-羟基-1-氮杂螺[4.5]癸-3-烯-2-酮，用于治疗目的，以及制药组合物和它们在治疗中的用途，特别是用于肿瘤疾病的预防和治疗。
• Substituted amino acids as integrin inhibitors
  申请人：Pliant Therapeutics, Inc.

  公开号：US11180494B2

  公开（公告）日：2021-11-23

  The invention relates to compounds of formula (I): or a salt thereof, wherein R1, G, L1, L2, L3, and Y are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are inhibitors of one, or both of, αvβ1 integrin and αvβ6 integrin that are useful for treating fibrosis such as in nonalcoholic steatohepatitis (NASH), idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).

  本发明涉及式 (I) 化合物： 或其盐，其中 R1、G、L1、L2、L3 和 Y 如本文所述。式（I）化合物及其药物组合物是αvβ1整合素和αvβ6整合素中一种或两种的抑制剂，可用于治疗纤维化，如非酒精性脂肪性肝炎（NASH）、特发性肺纤维化（IPF）和非特异性间质性肺炎（NSIP）。